Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Junshi Biosciences Receives FDA Approval for PI3K-α Inhibitor RP903 in Breast Cancer Study

March 3, 2025
CompanyDrug

InnoCare Pharma’s Guangzhou Plant Approved for Orelabrutinib Commercial Production

March 3, 2025
CompanyDrug

Hengrui Medicine’s Generic Tacrolimus Wins NMPA Approval for Transplant Rejection Prevention

March 3, 2025
Company

Medtronic Kanghui and Changzhou High-Tech Zone Partner on Science Park

March 3, 2025
Policy / Regulatory

NHC Releases Technical Guidelines for Drug Clinical Evaluation

March 3, 2025
CompanyDeals

HitGen and Haichang Bio Partner to Develop Anti-Cancer RNAi Drugs

March 3, 2025
Policy / Regulatory

Hainan Medical Products Administration Issues Guidelines for Imported Drug Management

March 3, 2025
CompanyDrug

Abbisko Therapeutics Doses First Patient in ABSK061 Phase I Study for Solid Tumors

March 3, 2025
CompanyDrug

Ascletis Pharma Doses First Patient in ASC22 HIV Study with Chidamide

March 3, 2025
CompanyDeals

Fosun Pharmaceutical and ReNeuron Renew CTX Cell Therapy Deal for China

March 3, 2025
Company

Eurofins DiscoverX Opens Shanghai Office to Expand Asia-Pacific Operations

March 3, 2025
CompanyDeals

Solasia Pharma Reduces China Operations, Transfers Drug Rights to Lee’s

March 3, 2025
1 2 … 18 19 20 21
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up